Expression of human tumor-associated antigen RCAS1 in adult T-cell leukemia/lymphoma

International Journal of Hematology

Volumn 79, Issue 4, 2004, Pages 340-344

  Muta, Koichiro ^a,d   Ohshima, Koichi ^b   Abe, Yasunobu ^a   Uike, Naokuni ^c   Choi, Ilseung ^a   Matsushima, Takamitsu ^a   Nishimura, Junji ^d   Kikuchi, Masahiro ^b   Nakashima, Manabu ^d   Watanabe, Takeshi ^d   Nawata, Hajime ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b FUKUOKA UNIVERSITY   (Japan)

^c NATIONAL KYUSHU CANCER CENTER   (Japan)

^d KYUSHU UNIVERSITY   (Japan)

Author keywords

Adult T cell leukemia lymphoma; Malignant lymphoma; RCAS1

Indexed keywords

PROTEIN RCAS1; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIGEN EXPRESSION; ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE BIOPSY; MALE; PROGNOSIS; SURVIVAL TIME; T CELL LEUKEMIA; T CELL LYMPHOMA;

EID: 2942512768     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1532/IJH97.03109     Document Type: Article

References (15)

1. Yamada Y, Tomonaga M. The current status of therapy for adult T-cell leukaemia-lymphoma in Japan. Leuk Lymphoma. 2003;44:611-618.
2. Nakashima M, Sonoda K, Watanabe T. Inhibition of cell growth and induction of apoptotic cell death by the human tumor-associated antigen RCAS1. Nat Med. 1999;5:938-942.
3. Sonoda K, Nakashima M, Saito T, et al. Establishment of a new human uterine cervical adenocarcinoma cell line SiSo, and its reactivity to anti-cancer reagents. Int J Oncol. 1995;6:1099-1104.
4. Sonoda K, Nakashima M, Kaku T, Kamura T, Nakano H, Watanabe T. A novel tumor-associated antigen expressed in human uterine and ovarian carcinomas. Cancer. 1996;77:1501-1509.
5. Sonoda K, Kaku T, Kamura T, Nakashima M, Watanabe T, Nakano H. Tumor-associated antigen 22-1-1 expression in the uterine cervical squamous neoplasia. Clin Cancer Res. 1998;4:1517-1520.
6. Usuku K, Sonoda S, Osame M, et al. HLA haplotype-linked high immune responsiveness against HTLV-I in HTLV-I-associated myelopathy: comparison with adult T-cell leukemia/lymphoma. Ann Neurol. 1988;23(suppl):S143-S150.
7. + cytotoxic T lymphocytes. AIDS Res Hum Retroviruses. 2001;20:1047-1061.
8. Strand S, Hofmann WJ, Hug H, et al. Lymphocyte apoptosis induced by CD95 (APO-1/Fas) ligand-expressing tumor cells: a mechanism of immune evasion? Nat Med. 1996;2:1361-1366.
9. Kaku T, Sonoda K, Kamura T, et al. The prognostic significance of tumor-associated antigen 22-1-1 expression in adenocarcinoma of the uterine cervix. Clin Cancer Res. 1999;5:1449-1453.
10. Arima N, Tei C. HTLV-I Tax related dysfunction of cell cycle regulators and oncogenesis of adult T cell leukemia. Leuk Lymphoma. 2001;40:267-278.
11. Kanavaros T, Bai M, Stefanaki K, et al. Immunohistochemical expression of the p53, mdm2, p21/Waf-1, Rb, p16, Ki67, cyclin D1, cyclin A and cyclin B1 proteins and apoptotic index in T-cell lymphomas. Histol Histopathol. 2001;16:377-386.
12. Oshima K, Haraoka S, Sugihara M, et al. Amplification and expression of a decoy receptor for Fas ligand (DcR3) in virus (EBV or HTLV-I) associated lymphomas. Cancer Lett. 2000;160:89-97.
13. Oshima K, Muta K, Nakashima N, et al. Expression of human tumor-associated antigen RCAS1 in Reed-Sternberg cells in association with Epstein-Barr virus infection: a potential mechanism of immune evasion. Int J Cancer. 2001;93:91-96.
14. Abe Y, Yashiki S, Choi I, et al. Eradication of virus-infected T-cells in a case of adult T-cell leukemia/lymphoma by nonmyeloablative peripheral blood stem cell transplantation with conditioning consisting of low-dose total body irradiation and pentostatin. Int J Hematol. 2002;76:91-93.
15. Utsunomiya A, Miyazaki Y, Takatsuki Y, et al. Improved outcome of adult T cell leukemia/lymphoma with allogeneic hematopoietic stem cell transplantation. Bone Marrow Transplant. 2001;27:15-20.